cardiogenic shock

Summary

Summary: Shock resulting from diminution of cardiac output in heart disease.

Top Publications

  1. Samuels L, Darze E. Management of acute cardiogenic shock. Cardiol Clin. 2003;21:43-9 pubmed
    ..Although the acute cardiogenic shock patient remains problematic, we now have at our disposable a variety of tools that have enabled us to ..
  2. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter J, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2010;38:152-60 pubmed publisher
    Patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction with cardiogenic shock (CS) are often treated with intra-aortic balloon pump counterpulsation (IABP), even though the evidence to support this ..
  3. Wu X, Chen J, Wu C, Lin L, Tseng C. Pheochromocytoma presenting as acute myocarditis with cardiogenic shock in two cases. Intern Med. 2008;47:2151-5 pubmed
    ..arrhythmias, angina pectoris, acute myocardial infarction, dilated cardiomyopathy, acute heart failure, and cardiogenic shock, have occasionally been reported...
  4. Sjauw K, Engstrom A, Vis M, van der Schaaf R, Baan J, Koch K, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J. 2009;30:459-68 pubmed publisher
    Aims Intra-aortic balloon counterpulsation (IABP) in ST-segment elevation myocardial infarction (STEMI) with cardiogenic shock is strongly recommended (class IB) in the current guidelines...
  5. Chuang Y, Ueng K. Spontaneous and simultaneous multivessel coronary spasm causing multisite myocardial infarction, cardiogenic shock, atrioventricular block, and ventricular fibrillation. Circ J. 2009;73:1961-4 pubmed
    ..variant angina developed simultaneous anterior and inferior myocardial infarction, atrioventricular block, cardiogenic shock, and eventually ventricular fibrillation...
  6. Goldberg R, Spencer F, Gore J, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119:1211-9 pubmed publisher
    ..is available about potentially changing and contemporary trends in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction...
  7. den Uil C, Lagrand W, van der Ent M, Jewbali L, Brugts J, Spronk P, et al. The effects of intra-aortic balloon pump support on macrocirculation and tissue microcirculation in patients with cardiogenic shock. Cardiology. 2009;114:42-6 pubmed publisher
    ..It was the aim of this study to evaluate the effects of intra-aortic balloon pump (IABP) counterpulsation on sublingual microcirculation as a model for tissue perfusion...
  8. Jung C, Ferrari M, Rödiger C, Fritzenwanger M, Goebel B, Lauten A, et al. Evaluation of the sublingual microcirculation in cardiogenic shock. Clin Hemorheol Microcirc. 2009;42:141-8 pubmed publisher
    ..Patients with cardiogenic shock (n=7) had lower microflow compared with patients without cardiogenic shock (small p<0.001, medium p<0...
  9. Cheng J, den Uil C, Hoeks S, van der Ent M, Jewbali L, van Domburg R, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102-8 pubmed publisher
    ..ventricular assist devices (LVADs) with intra-aortic balloon pump (IABP) counterpulsation in patients with cardiogenic shock. We performed a meta-analysis of controlled trials to evaluate potential benefits of percutaneous LVAD on ..

More Information

Publications32

  1. Camaro C, Wouters N, Gin M, Bosker H. Acute myocardial infarction with cardiogenic shock in a patient with acute aortic dissection. Am J Emerg Med. 2009;27:899.e3-6 pubmed publisher
    ..remains challenging for the emergency physician because it can resemble acute myocardial infarction with cardiogenic shock. The following case report illustrate this infrequent but critical situation...
  2. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott Flügel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584-8 pubmed publisher
    ..b>Cardiogenic shock caused by left ventricular failure is associated with high mortality in patients with acute myocardial ..
  3. Torgersen C, Schmittinger C, Wagner S, Ulmer H, Takala J, Jakob S, et al. Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study. Crit Care. 2009;13:R157 pubmed publisher
    ..the question as to which hemodynamic variables are associated with outcome or should be targeted in cardiogenic shock patients...
  4. Aziz T, Singh G, Popjes E, Stephenson E, Mulvey S, Pae W, et al. Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J Heart Lung Transplant. 2010;29:66-71 pubmed publisher
    b>Cardiogenic shock refractory to conventional therapy has very high mortality and limited support options...
  5. Wang J, Han J, Jia Y, Zeng W, Shi J, Hou X, et al. Early and intermediate results of rescue extracorporeal membrane oxygenation in adult cardiogenic shock. Ann Thorac Surg. 2009;88:1897-903 pubmed publisher
    ..05). Extracorporeal membrane oxygenation is an acceptable technique for the treatment of postoperative cardiogenic shock in adults, although early intervention and reduced complications could improve results...
  6. Song B, Park S, Noh H, Jo H, Choi J, Lee S, et al. Clinical characteristics, and laboratory and echocardiographic findings in takotsubo cardiomyopathy presenting as cardiogenic shock. J Crit Care. 2010;25:329-35 pubmed publisher
    ..there are few data regarding clinical, laboratory, and echocardiographic findings in TTC presenting as cardiogenic shock. We aimed to assess the differences in these parameters between TTC presenting with and without cardiogenic ..
  7. Götberg M, Van der Pals J, Olivecrona G, Götberg M, Koul S, Erlinge D. Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model. Resuscitation. 2010;81:1190-6 pubmed publisher
    b>Cardiogenic shock is the main cause of death in patients hospitalized due to an acute myocardial infarction. Mild hypothermia reduces metabolism and could offer protective effects for this condition...
  8. How O, Røsner A, Kildal A, Stenberg T, Gjessing P, Hermansen S, et al. Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock. Transl Res. 2010;156:273-81 pubmed publisher
    We assessed the hemodynamic effects of guideline therapy in experimental cardiogenic shock and compared this treatment with a combination containing an alternative vasopressor (arginine vasopressin, AVP)...
  9. Jeger R, Radovanovic D, Hunziker P, Pfisterer M, Stauffer J, Erne P, et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008;149:618-26 pubmed
    Few studies describe recent changes in the incidence, treatment, and outcomes of cardiogenic shock. To examine temporal trends in the incidence, therapeutic management, and mortality rates of patients with the acute coronary syndrome (..
  10. Link A, Girndt M, Selejan S, Rbah R, Bohm M. Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study. Crit Care. 2008;12:R111 pubmed publisher
    Approximately one third of all patients with cardiogenic shock suffer from acute kidney injury...
  11. Fuhrmann J, Schmeisser A, Schulze M, Wunderlich C, Schoen S, Rauwolf T, et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2008;36:2257-66 pubmed publisher
    b>Cardiogenic shock is the leading cause of death in patients hospitalized for acute myocardial infarction...
  12. Sichrovsky T, Mittal S, Steinberg J. Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg. 2008;106:1784-6 pubmed publisher
    ..The patient developed unexplained and refractory cardiogenic shock and could not be resuscitated. Autopsy failed to demonstrate any abnormality or cause of death...
  13. Ding X, Chen G, Liu Y. [Effects of shengmai for injection on cardiogenic shock]. Zhongguo Zhong Yao Za Zhi. 2007;32:2298-305 pubmed
    To study the protective effects and the possible mechanism of shengmai for injection(SM) against the experimental acute cardiogenic shock.
  14. Yorgun H, Deniz A, Aytemir K. Cardiogenic shock secondary to combination of diltiazem and sotalol. Intern Med J. 2008;38:221-2 pubmed publisher
  15. Reynolds H, Hochman J. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686-97 pubmed publisher
  16. Idelchik G, Simpson L, Civitello A, Loyalka P, Gregoric I, Delgado R, et al. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008;27:106-11 pubmed publisher
    For patients with persistent cardiogenic shock refractory to intraaortic balloon pump (IABP) support, there are only limited means of resuscitation and bridging to surgical left ventricular assist device (LVAD) implantation...
  17. Topalian S, Ginsberg F, Parrillo J. Cardiogenic shock. Crit Care Med. 2008;36:S66-74 pubmed publisher
    b>Cardiogenic shock is the most common cause of death in patients hospitalized with acute myocardial infarction and is associated with a poor prognosis...
  18. Smetana P, Geppert A. Levosimendan in cardiogenic shock: the magic drug for every patient?. Crit Care Med. 2007;35:2862-4 pubmed
  19. Schmidt W, Reissig M, Neuhaus K. [Percutaneous extracorporeal circulation in cardiogenic shock caused by combined poisoning with methyldigoxin, nifedipine and indapamide]. Dtsch Med Wochenschr. 1995;120:996-1002 pubmed
  20. Fincke R, Hochman J, Lowe A, Menon V, Slater J, Webb J, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol. 2004;44:340-8 pubmed
    We sought to analyze clinical, angiographic, and outcome correlates of hemodynamic parameters in cardiogenic shock. The significance of right heart catheterization in critically ill patients is controversial, despite the prognostic ..
  21. Picard M, Davidoff R, Sleeper L, Mendes L, Thompson C, Dzavik V, et al. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation. 2003;107:279-84 pubmed
    ..has not been established whether specific features of cardiac structure or function early in the course of cardiogenic shock provide prognostic value...
  22. Dauerman H, Goldberg R, White K, Gore J, Sadiq I, Gurfinkel E, et al. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2002;90:838-42 pubmed
    ..in mortality with early revascularization of patients with acute myocardial infarction (AMI) complicated by cardiogenic shock, and recent single-center studies have particularly suggested further benefit for coronary stenting...
  23. Hochman J, Sleeper L, White H, Dzavik V, Wong S, Menon V, et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190-2 pubmed
    b>Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute myocardial infarction (AMI). To assess the effect of early revascularization (ERV) on 1-year survival for patients with AMI complicated by CS...